ShowStaticCategory

	Mr Gary Garton - Chairman Mr. Garton is an experienced Chief Executive Officer and public company director with a domestic and international background in the service, software and manufacturing industries. Mr. Garton was President and Chief Executive Officer of Brinks Inc. for 10 years, the largest security transportation and armoured car company in the US. Prior to moving to the US he was an Executive Director of Brambles Holdings Limited. Mr. Garton was Chief Executive Officer and Managing Director of the gaming company Aristocrat Leisure Limited and successfully led Aristocrat through its initial public offering and listing on the ASX. Mr. Garton is Chairman of the publicly listed Odyssey Gaming Limited. Mr. Garton was appointed to the board on 9 October 2006.




	Mr David Young - Managing Director Mr. Young was previously Group Managing Director and CEO of Australian Pharmaceutical Industries Limited, an integrated health services business operating across Australia and New Zealand with a turnover in excess of A$3 billion. Prior to this, Mr. Young was Group Managing Director at Hallenstein Glasson Holdings Limited, a New Zealand based specialty fashion retailer with over 100 stores in New Zealand and Australia. He spent 10 years abroad in senior international roles at Dairy Farm International running multiple businesses in various South East Asian countries. Mr. Young also had12 years with Target Australia Pty Limited in State and National roles in buying and marketing. He holds an Executive MBA from the University of Virginia. Mr. Young was appointed to the board on 9 October 2006.




	Dr Ronald Shnier - Director Dr. Shnier is the Director of Symbion Imaging Clinical Research Imaging Centre and National Director of Research and Professional Development at Symbion Imaging, divisions of Symbion Health Care Limited. Prior to this Dr. Shnier was Director MRI services Sydney Imaging Group and Chairman Sydney Imaging Group and has held a number of prominent medical roles at leading hospitals. Dr. Shnier was appointed to the board on 9 November 2006.